Cargando…
Nod2: The intestinal gate keeper
Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan (PGN)-conserved motifs in cytosol and stimulates host immune response. The association of NOD2 mutations with a number of inflammatory pathologies, including Crohn...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333895/ https://www.ncbi.nlm.nih.gov/pubmed/28253332 http://dx.doi.org/10.1371/journal.ppat.1006177 |
_version_ | 1782511792155525120 |
---|---|
author | Al Nabhani, Ziad Dietrich, Gilles Hugot, Jean-Pierre Barreau, Frederick |
author_facet | Al Nabhani, Ziad Dietrich, Gilles Hugot, Jean-Pierre Barreau, Frederick |
author_sort | Al Nabhani, Ziad |
collection | PubMed |
description | Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan (PGN)-conserved motifs in cytosol and stimulates host immune response. The association of NOD2 mutations with a number of inflammatory pathologies, including Crohn disease (CD), Graft-versus-host disease (GVHD), and Blau syndrome, highlights its pivotal role in host–pathogen interactions and inflammatory response. Stimulation of NOD2 by its ligand (muramyl dipeptide) activates pro-inflammatory pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinases (MAPKs), and Caspase-1. A loss of NOD2 function may result in a failure in the control of microbial infection, thereby initiating systemic responses and aberrant inflammation. Because the ligand of Nod2 is conserved in both gram-positive and gram-negative bacteria, NOD2 detects a wide variety of microorganisms. Furthermore, current literature evidences that NOD2 is also able to control viruses’ and parasites’ infections. In this review, we present and discuss recent developments about the role of NOD2 in shaping the gut commensal microbiota and pathogens, including bacteria, viruses, and parasites, and the mechanisms by which Nod2 mutations participate in disease occurrence. |
format | Online Article Text |
id | pubmed-5333895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53338952017-03-10 Nod2: The intestinal gate keeper Al Nabhani, Ziad Dietrich, Gilles Hugot, Jean-Pierre Barreau, Frederick PLoS Pathog Review Nucleotide-binding oligomerization domain 2 (NOD2) is an intracellular pattern recognition receptor that senses bacterial peptidoglycan (PGN)-conserved motifs in cytosol and stimulates host immune response. The association of NOD2 mutations with a number of inflammatory pathologies, including Crohn disease (CD), Graft-versus-host disease (GVHD), and Blau syndrome, highlights its pivotal role in host–pathogen interactions and inflammatory response. Stimulation of NOD2 by its ligand (muramyl dipeptide) activates pro-inflammatory pathways such as nuclear factor-κB (NF-κB), mitogen-activated protein kinases (MAPKs), and Caspase-1. A loss of NOD2 function may result in a failure in the control of microbial infection, thereby initiating systemic responses and aberrant inflammation. Because the ligand of Nod2 is conserved in both gram-positive and gram-negative bacteria, NOD2 detects a wide variety of microorganisms. Furthermore, current literature evidences that NOD2 is also able to control viruses’ and parasites’ infections. In this review, we present and discuss recent developments about the role of NOD2 in shaping the gut commensal microbiota and pathogens, including bacteria, viruses, and parasites, and the mechanisms by which Nod2 mutations participate in disease occurrence. Public Library of Science 2017-03-02 /pmc/articles/PMC5333895/ /pubmed/28253332 http://dx.doi.org/10.1371/journal.ppat.1006177 Text en © 2017 Al Nabhani et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Al Nabhani, Ziad Dietrich, Gilles Hugot, Jean-Pierre Barreau, Frederick Nod2: The intestinal gate keeper |
title | Nod2: The intestinal gate keeper |
title_full | Nod2: The intestinal gate keeper |
title_fullStr | Nod2: The intestinal gate keeper |
title_full_unstemmed | Nod2: The intestinal gate keeper |
title_short | Nod2: The intestinal gate keeper |
title_sort | nod2: the intestinal gate keeper |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333895/ https://www.ncbi.nlm.nih.gov/pubmed/28253332 http://dx.doi.org/10.1371/journal.ppat.1006177 |
work_keys_str_mv | AT alnabhaniziad nod2theintestinalgatekeeper AT dietrichgilles nod2theintestinalgatekeeper AT hugotjeanpierre nod2theintestinalgatekeeper AT barreaufrederick nod2theintestinalgatekeeper |